Champions Oncology (CSBR) FCF Margin Growth (3y) (2013 - 2026)
Powered by 
Analysis
Champions Oncology (CSBR) FCF Margin Growth (3y) (2013 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FCF Margin Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Iqvia Holdings | 44.72 Bn | 42.64 Bn | 1.44 Bn | 175.00 |
| 2 | Medpace Holdings | 17.37 Bn | 16.87 Bn | 201.64 Mn | 345.00 |
| 3 | Icon | 13.65 Bn | 12.72 Bn | 479.29 Mn | 400.00 |
| 4 | Charles River Laboratories International | 13.13 Bn | 12.94 Bn | 452.07 Mn | 718.00 |
| 5 | Fortrea Holdings | 1.89 Bn | 1.72 Bn | 139.20 Mn | -1,644.00 |
| 6 | Evotec SE | 574.75 Mn | 148.87 Mn | - | - |
| 7 | Ginkgo Bioworks Holdings | 439.63 Mn | 355.09 Mn | 18.44 Mn | -12,458.00 |
| 8 | Champions Oncology | 69.43 Mn | 65.03 Mn | 7.70 Mn | 3,304.00 |
| 9 | MindWalk Holdings | 51.76 Mn | 46.29 Mn | 1.61 Mn | -9,606.00 |
| 10 | VivoSim Labs | 1.37 Mn | 1.37 Mn | - | -1.09 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jul 31, 2026 | 3,304.00 |
| Apr 30, 2026 | -506.00 |
| Jan 31, 2026 | -1,472.00 |
| Oct 31, 2025 | -3,033.00 |
| Jul 31, 2025 | 915.00 |
| Apr 30, 2025 | 5,365.00 |
| Jan 31, 2025 | -2,828.00 |
| Oct 31, 2024 | -841.00 |
| Jul 31, 2024 | 835.00 |
| Apr 30, 2024 | 1,388.00 |
| Jan 31, 2024 | 147.00 |
| Oct 31, 2023 | 72.00 |
| Jul 31, 2023 | -2,208.00 |
| Apr 30, 2023 | -2,275.00 |
| Jan 31, 2023 | 521.00 |
| Oct 31, 2022 | 1,108.00 |
| Jul 31, 2022 | 835.00 |
| Apr 30, 2022 | 81.00 |
| Jan 31, 2022 | 1,360.00 |
| Oct 31, 2021 | 877.00 |